MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$109,720K
EPS
-$1.52
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
60,080
86,011
45,838*
56,473
General and administrative
52,410
39,121
17,840*
27,459
Total operating expenses
112,490
125,132
63,678
83,932
Loss from operations
-112,490
-125,132
-63,678*
-83,932
Interest income
5,348
6,355
7,271*
5,736
Interest expense
1,848
1,823
1,651*
1,960
Other expense, net
-483
-432
-678*
-137
Total other income, net
3,017
4,100
4,942*
3,639
Loss before provision for income taxes
-
-
-58,736*
-
Provision for income taxes
-
-
0*
-
Net loss
-109,473
-121,032
-58,736*
-80,293
Change in unrealized losss and gaines on marketable securities
-247
-942
-669*
354
Comprehensive loss
-109,720
-121,974
-59,405
-79,939
Basic EPS
-1.52
-1.69
-0.919
-1.26
Diluted EPS
-1.52
-1.69
-0.919
-1.26
Basic Average Shares
71,838,008
71,476,595
64,620,573
63,847,055
Diluted Average Shares
71,838,008
71,476,595
64,620,573
63,847,055
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$109,720K
Interest income
$5,348K
Net loss
-$109,473K
Change in unrealized
losss and gaines on...
-$247K
Total other income,
net
$3,017K
Interest expense
$1,848K
Other expense, net
-$483K
Loss from operations
-$112,490K
Total operating
expenses
$112,490K
Research and development
$60,080K
General and
administrative
$52,410K
Buy us a coffee
Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA)